Cosan says Rumo poison pill changes require shareholder approval

PUBT · 1d ago
Cosan says Rumo poison pill changes require shareholder approval
  • Cosan remains in talks over a potential partial sale of its Rumo stake, evaluating alternative transaction structures.
  • Any change to Rumo's poison pill would require shareholder approval at an extraordinary general meeting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosan SA published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.